ArticleBioactive materials2026
Robust adhesive, antibacterial, pro-angiogenic and osteogenic bone adhesives with moderate degradability facilitating bone regeneration.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Bioadhesive-Integrated 3D-Printed Multilayer Scaffolds Secure a Mechanically-Stable Osteoimmune Niche for Enhanced Bone Augmentation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Novel injectable and wet bonding bone adhesive: physicochemical characterization and biocompatibility evaluation.BMC oral health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional bone repair technologies such as using metal implants and autologous bone grafts, are limited due to immune rejection, donor availability, the need for secondary surgeries, and material fatigue. Here, we demonstrated a novel multifunctional bone adhesive by mixing poly (ethylene glycol) succinimidyl glutarate (PEG-SG) with tannic acid (TA), copper oxide (CuO), bioactive glass (BG), and gelatin for sealing cranial defects and facilitating bone regeneration. In the porous bone adhesive, the PEG-SG was formed into an interconnected matrix, while TA served as a polyphenolic crosslinker that reinforced interfacial adhesion and mechanical strength. The PEG-SG/TA/CuO/BG/Gel bone adhesive was biodegradable and bioactive by releasing Cu
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.